Transcriptome analysis in mitochondrial disorders

Brain Research Bulletin

Volumn 88, Issue 4, 2012, Pages 285-293

  Elstner, Matthias ^a   Turnbull, Douglass M ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cell cycle; Epigenetics; Gene expression; Microarray; Mitochondrial biogenesis; Mitochondrial disease; OXPHOS; PGC 1

Indexed keywords

ASPARTATE AMMONIA LIGASE; CYCLIN DEPENDENT KINASE; MITOCHONDRIAL DNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME; TRANSFER RNA;

APOPTOSIS; AUTOPHAGY; BIOGENESIS; CALCIUM SIGNALING; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM STRESS; ENERGY CONSUMPTION; ENZYME SUBSTRATE; EPIGENETICS; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC REGULATION; GENOME ANALYSIS; GENOMIC INSTABILITY; GLUCOSE OXIDATION; HEARING LOSS; HOMEOSTASIS; INHIBITION KINETICS; LEBER HEREDITARY OPTIC NEUROPATHY; MELAS SYNDROME; MICROARRAY ANALYSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; MUTATIONAL ANALYSIS; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; MITOCHONDRIAL DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84862207715     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.07.018     Document Type: Review

References (91)

1. DiMauro S., Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348:2656-2668.
2. McFarland R., Taylor R.W., Turnbull D.M. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010, 9:829-840.
3. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
4. Onyango I.G., Lu J., Rodova M., Lezi E., Crafter A.B., Swerdlow R.H. Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochim. Biophys. Acta 2010, 1802:228-234.
5. Gibson G.E., Starkov A., Blass J.P., Ratan R.R., Beal M.F. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim. Biophys. Acta 2010, 1802:122-134.
6. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
7. Mair W., Dillin A. Aging and survival: the genetics of life span extension by dietary restriction. Annu. Rev. Biochem. 2008, 77:727-754.
8. Finley L.W.S., Haigis M.C. The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res. Rev. 2009, 8:173-188.
9. Scarpulla R.C. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 2008, 88:611-638.
10. Hock M.B., Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 2009, 71:177-203.
11. Taylor R.W., Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 2005, 6:389-402.
12. Holt I.J., Harding A.E., Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988, 331:717-719.
13. Zeviani M., Moraes C.T., DiMauro S., Nakase H., Bonilla E., Schon E.A., Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988, 38:1339-1346.
14. Wallace D.C., Singh G., Lott M.T., Hodge J.A., Schurr T.G., Lezza A.M., Elsas L.J., Nikoskelainen E.K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988, 242:1427-1430.
15. McFarland R., Taylor R.W., Turnbull D.M. Mitochondrial disease-its impact, etiology, and pathology. Curr. Top. Dev. Biol. 2007, 77:113-155.
16. Falkenberg M., Larsson N.-G., Gustafsson C.M. DNA replication and transcription in mammalian mitochondria. Annu. Rev. Biochem. 2007, 76:679-699.
17. Shoubridge E.A. Nuclear gene defects in respiratory chain disorders. Semin. Neurol. 2001, 21:261-267.
18. Ekstrand M.I., Falkenberg M., Rantanen A., Park C.B., Gaspari M., Hultenby K., Rustin P., Gustafsson C.M., Larsson N.-G. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 2004, 13:935-944.
19. Smits P., Smeitink J., van den Heuvel L. Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J. Biomed. Biotechnol. 2010, 2010:737385.
20. Saada A. Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell. Biol. 2004, 23:797-806.
21. van Waveren C., Moraes C.T. Transcriptional co-expression and co-regulation of genes coding for components of the oxidative phosphorylation system. BMC Genomics 2008, 9:18.
22. Neupert W., Herrmann J.M. Translocation of proteins into mitochondria. Annu. Rev. Biochem. 2007, 76:723-749.
23. Pecina P., Houstkova H., Hansikova H., Zeman J., Houstek J. Genetic defects of cytochrome c oxidase assembly. Physiol. Res. 2004, 53(Suppl. 1):S213-S223.
24. Elstner M., Andreoli C., Ahting U., Tetko I., Klopstock T., Meitinger T., Prokisch H. MitoP2: an integrative tool for the analysis of the mitochondrial proteome. Mol. Biotechnol. 2008, 40:306-315.
25. Jacobs H.T., Turnbull D.M. Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet. 2005, 21:312-314.
26. Kemp J.P., Smith P.M., Pyle A., Neeve V.C., Tuppen H.A., Schara U., Talim B., Topaloglu H., Holinski-Feder E., Abicht A., Czermin B., Lochmuller H., McFarland R., Chinnery P.F., Chrzanowska-Lightowlers Z.M., Lightowlers R.N., Taylor R.W., Horvath R. Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 2011, 134:183-195.
27. Haack T.B., Danhauser K., Haberberger B., Hoser J., Strecker V., Boehm D., Uziel G., Lamantea E., Invernizzi F., Poulton J., Rolinski B., Iuso A., Biskup S., Schmidt T., Mewes H.W., Wittig I., Meitinger T., Zeviani M., Prokisch H. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat. Genet. 2010, 42:1131-1134.
28. McFarland R., Elson J.L., Taylor R.W., Howell N., Turnbull D.M. Assigning pathogenicity to mitochondrial tRNA mutations: when definitely maybe is not good enough. Trends Genet. 2004, 20:591-596.
29. Greaves L.C., Yu-Wai-Man P., Blakely E.L., Krishnan K.J., Beadle N.E., Kerin J., Barron M.J., Griffiths P.G., Dickinson A.J., Turnbull D.M., Taylor R.W. Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO. Invest. Ophthalmol. Vis. Sci. 2010, 51:3340-3346.
30. Chinnery P.F., Taylor D.J., Manners D., Styles P., Lodi R. No correlation between muscle A3243G mutation load and mitochondrial function in vivo. Neurology 2001, 56:1101-1104.
31. Carelli V., Giordano C., d'Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 2003, 19:257-262.
32. Swalwell H., Blakely E.L., Sutton R., Tonska K., Elstner M., He L., Taivassalo T., Burns D.K., Turnbull D.M., Haller R.G., Davidson M.M., Taylor R.W. A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?. Eur. J. Hum. Genet. 2008, 16:1265-1274.
33. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., Letellier T. Mitochondrial threshold effects. Biochem. J. 2003, 370:751-762.
34. Ogasawara E., Nakada K., Hayashi J.-I. Lactic acidemia in the pathogenesis of mice carrying mitochondrial DNA with a deletion. Hum. Mol. Genet. 2010, 19:3179-3189.
35. Krishnan K.J., Greaves L.C., Reeve A.K., Turnbull D. The ageing mitochondrial genome. Nucleic Acids Res. 2007, 35:7399-7405.
36. Kirkman M.A., Yu-Wai-Man P., Korsten A., Leonhardt M., Dimitriadis K., De Coo I.F., Klopstock T., Chinnery P.F. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009, 132:2317-2326.
37. Buesa C., Maes T., Subirada F., Barrachina M., Ferrer I. DNA chip technology in brain banks: confronting a degrading world. J. Neuropathol. Exp. Neurol. 2004, 63:1003-1014.
38. Vawter M.P., Tomita H., Meng F., Bolstad B., Li J., Evans S., Choudary P., Atz M., Shao L., Neal C., Walsh D.M., Burmeister M., Speed T., Myers R., Jones E.G., Watson S.J., Akil H., Bunney W.E. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol. Psychiatry 2006, 11(615):663-679.
39. Graeber M.B. Twenty-first century brain banking: at the crossroads. Acta Neuropathol. 2008, 115:493-496.
40. Heddi A., Lestienne P., Wallace D.C., Stepien G. Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J. Biol. Chem. 1993, 268:12156-12163.
41. Heddi A., Lestienne P., Wallace D.C., Stepien G. Steady state levels of mitochondrial and nuclear oxidative phosphorylation transcripts in Kearns-Sayre syndrome. Biochim. Biophys. Acta 1994, 1226:206-212.
42. Heddi A., Stepien G., Benke P.J., Wallace D.C. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J. Biol. Chem. 1999, 274:22968-22976.
43. Alesci S., Manoli I., Michopoulos V.J., Brouwers F.M., Le H., Gold P.W., Blackman M.R., Rennert O.M., Su Y.A., Chrousos G.P. Development of a human mitochondria-focused cDNA microarray (hMitChip) and validation in skeletal muscle cells: implications for pharmaco- and mitogenomics. Pharmacogenomics J. 2006, 6:333-342.
44. Bai X., Wu J., Zhang Q., Alesci S., Manoli I., Blackman M.R., Chrousos G.P., Goldstein A.L., Rennert O.M., Su Y.A. Third-generation human mitochondria-focused cDNA microarray and its bioinformatic tools for analysis of gene expression. Biotechniques 2007, 42:365-375.
45. Cízková A., Stránecký V., Ivánek R., Hartmannová H., Nosková L., Piherová L., Tesarová M., Hansíková H., Honzík T., Zeman J., Divina P., Potocká A., Paul J., Sperl W., Mayr J.A., Seneca S., Houstěk J., Kmoch S. Development of a human mitochondrial oligonucleotide microarray (h-MitoArray) and gene expression analysis of fibroblast cell lines from 13 patients with isolated F1Fo ATP synthase deficiency. BMC Genomics 2008, 9:38.
46. Voss J.G., Raju R., Logun C., Danner R.L., Munson P.J., Rangel Z., Dalakas M.C. A focused microarray to study human mitochondrial and nuclear gene expression. Biol. Res. Nurs. 2008, 9:272-279.
47. Subramaniam V., Golik P., Murdock D.G., Levy S., Kerstann K.W., Coskun P.E., Melkonian G.A., Wallace D.C. MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes. Biochim. Biophys. Acta 2008, 1777:666-675.
48. King M.P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 1989, 246:500-503.
49. Behan A., Doyle S., Farrell M. Adaptive responses to mitochondrial dysfunction in the rho degrees Namalwa cell. Mitochondrion 2005, 5:173-193.
50. Delsite R., Kachhap S., Anbazhagan R., Gabrielson E., Singh K.K. Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol. Cancer 2002, 1:6.
51. Danielson S.R., Carelli V., Tan G., Martinuzzi A., Schapira A.H.V., Savontaus M.-L., Cortopassi G.A. Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process. Brain 2005, 128:1026-1037.
52. Abramov A.Y., Smulders-Srinivasan T.K., Kirby D.M., Acin-Perez R., Enriquez J.A., Lightowlers R.N., Duchen M.R., Turnbull D.M. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. Brain 2010, 133:797-807.
53. Starkov A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann. N. Y. Acad. Sci. 2008, 1147:37-52.
54. McKenzie M., Liolitsa D., Hanna M.G. Mitochondrial disease: mutations and mechanisms. Neurochem. Res. 2004, 29:589-600.
55. Kirby D.M., Rennie K.J., Smulders-Srinivasan T.K., Acin-Perez R., Whittington M., Enriquez J.A., Trevelyan A.J., Turnbull D.M., Lightowlers R.N. Transmitochondrial embryonic stem cells containing pathogenic mtDNA mutations are compromised in neuronal differentiation. Cell Prolif. 2009, 42:413-424.
56. Abramov A.Y., Duchen M.R. Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons. Biochim. Biophys. Acta 2010, 1800:297-304.
57. Vesce S., Jekabsons M.B., Johnson-Cadwell L.I., Nicholls D.G. Acute glutathione depletion restricts mitochondrial ATP export in cerebellar granule neurons. J. Biol. Chem. 2005, 280:38720-38728.
58. van der Westhuizen F.H., van den Heuvel L.P., Smeets R., Veltman J.A., Pfundt R., van Kessel A.G., Ursing B.M., Smeitink J.A.M. Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray. Neuropediatrics 2003, 34:14-22.
59. Alemi M., Prigione A., Wong A., Schoenfeld R., DiMauro S., Hirano M., Taroni F., Cortopassi G. Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript. Free Radic. Biol. Med. 2007, 42:32-43.
60. Cortopassi G., Danielson S., Alemi M., Zhan S.S., Tong W., Carelli V., Martinuzzi A., Marzuki S., Majamaa K., Wong A. Mitochondrial disease activates transcripts of the unfolded protein response and cell cycle and inhibits vesicular secretion and oligodendrocyte-specific transcripts. Mitochondrion 2006, 6:161-175.
61. Chinnery P., Majamaa K., Turnbull D., Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. 2006, CD004426.
62. Paschen W., Frandsen A. Endoplasmic reticulum dysfunction-a common denominator for cell injury in acute and degenerative diseases of the brain?. J. Neurochem. 2001, 79:719-725.
63. Simmen T., Lynes E.M., Gesson K., Thomas G. Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim. Biophys. Acta 2010, 1798:1465-1473.
64. Wang J., Silva J.P., Gustafsson C.M., Rustin P., Larsson N.G. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:4038-4043.
65. Aure K., Fayet G., Leroy J.P., Lacene E., Romero N.B., Lombes A. Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation. Brain 2006, 129:1249-1259.
66. Nakase H., Moraes C.T., Rizzuto R., Lombes A., DiMauro S., Schon E.A. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am. J. Hum. Genet. 1990, 46:418-427.
67. Crimi M., Bordoni A., Menozzi G., Riva L., Fortunato F., Galbiati S., Del Bo R., Pozzoli U., Bresolin N., Comi G.P. Skeletal muscle gene expression profiling in mitochondrial disorders. FASEB J. 2005, 19:866-868.
68. Benard G., Bellance N., Jose C., Melser S., Nouette-Gaulain K., Rossignol R. Multi-site control and regulation of mitochondrial energy production. Biochim. Biophys. Acta 2010, 1797:698-709.
69. Wallace D.C. Bioenergetics and the epigenome: interface between the environment and genes in common diseases. Dev. Disabil. Res. Rev. 2010, 16:114-119.
70. Traven A., Wong J.M., Xu D., Sopta M., Ingles C.J. Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial dna mutant. J. Biol. Chem. 2001, 276:4020-4027.
71. Fujita Y., Ito M., Nozawa Y., Yoneda M., Oshida Y., Tanaka M. CHOP (C/EBP homologous protein) and ASNS (asparagine synthetase) induction in cybrid cells harboring MELAS and NARP mitochondrial DNA mutations. Mitochondrion 2007, 7:80-88.
72. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
73. Narendra D.P., Jin S.M., Tanaka A., Suen D.F., Gautier C.A., Shen J., Cookson M.R., Youle R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8:e1000298.
74. Geisler S., Holmstrom K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell. Biol. 2010, 12:119-131.
75. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129:111-122.
76. Aragones J., Schneider M., Van Geyte K., Fraisl P., Dresselaers T., Mazzone M., Dirkx R., Zacchigna S., Lemieux H., Jeoung N.H., Lambrechts D., Bishop T., Lafuste P., Diez-Juan A., Harten S.K., Van Noten P., De Bock K., Willam C., Tjwa M., Grosfeld A., Navet R., Moons L., Vandendriessche T., Deroose C., Wijeyekoon B., Nuyts J., Jordan B., Silasi-Mansat R., Lupu F., Dewerchin M., Pugh C., Salmon P., Mortelmans L., Gallez B., Gorus F., Buyse J., Sluse F., Harris R.A., Gnaiger E., Hespel P., Van Hecke P., Schuit F., Van Veldhoven P., Ratcliffe P., Baes M., Maxwell P., Carmeliet P. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 2008, 40:170-180.
77. Miranda S., Foncea R., Guerrero J., Leighton F. Oxidative stress and upregulation of mitochondrial biogenesis genes in mitochondrial DNA-depleted HeLa cells. Biochem. Biophys. Res. Commun. 1999, 258:44-49.
78. Wenz T., Diaz F., Spiegelman B.M., Moraes C.T. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell. Metab. 2008, 8:249-256.
79. Srivastava S., Diaz F., Iommarini L., Aure K., Lombes A., Moraes C.T. PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum. Mol. Genet. 2009, 18:1805-1812.
80. Bastin J., Aubey F., Rötig A., Munnich A., Djouadi F. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J. Clin. Endocrinol. Metab. 2008, 93:1433-1441.
81. Cazzalini O., Scovassi A.I., Savio M., Stivala L.A., Prosperi E. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 2010, 704:12-20.
82. Miceli M.V., Jazwinski S.M. Nuclear gene expression changes due to mitochondrial dysfunction in ARPE-19 cells: implications for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2005, 46:1765-1773.
83. Veatch J.R., McMurray M.A., Nelson Z.W., Gottschling D.E. Mitochondrial dysfunction leads to nuclear genome instability via an iron-sulfur cluster defect. Cell 2009, 137:1247-1258.
84. Wallace D.C., Fan W. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010, 10:12-31.
85. Kyriakouli D.S., Boesch P., Taylor R.W., Lightowlers R.N. Progress and prospects: gene therapy for mitochondrial DNA disease. Gene Ther. 2008, 15:1017-1023.
86. Craven L., Tuppen H.A., Greggains G.D., Harbottle S.J., Murphy J.L., Cree L.M., Murdoch A.P., Chinnery P.F., Taylor R.W., Lightowlers R.N., Herbert M., Turnbull D.M. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010, 465:82-85.
87. Wenz T., Williams S.L., Bacman S.R., Moraes C.T. Emerging therapeutic approaches to mitochondrial diseases. Dev. Disabil. Res. Rev. 2010, 16:219-229.
88. Chaturvedi R.K., Beal M.F. PPAR: a therapeutic target in Parkinson's disease. J. Neurochem. 2008, 106:506-518.
89. Arduino D.M., Esteves A.R., Oliveira C.R., Cardoso S.M. Mitochondrial metabolism modulation: a new therapeutic approach for Parkinson's disease. CNS Neurol. Disord. Drug Targets 2010, 9:105-119.
90. Zheng B., Liao Z., Locascio J.J., Lesniak K.A., Roderick S.S., Watt M.L., Eklund A.C., Zhang-James Y., Kim P.D., Hauser M.A., Grunblatt E., Moran L.B., Mandel S.A., Riederer P., Miller R.M., Federoff H.J., Wullner U., Papapetropoulos S., Youdim M.B., Cantuti-Castelvetri I., Young A.B., Vance J.M., Davis R.L., Hedreen J.C., Adler C.H., Beach T.G., Graeber M.B., Middleton F.A., Rochet J.C., Scherzer C.R. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med. 2010, 2:52ra73.
91. Bonod-Bidaud C., Giraud S., Mandon G., Mousson B., Stepien G. Quantification of OXPHOS gene transcripts during muscle cell differentiation in patients with mitochondrial myopathies. Exp. Cell. Res. 1999, 246:91-97.